Stonepine Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,130,192
| Closed | -$12.8M | – | 30 |
|
|
2022
Q1 | $12.8M | Buy |
3,130,192
+832,832
| +36% | +$3.41M | 5.32% | 7 |
|
|
2021
Q4 | $8.2M | Buy |
2,297,360
+2,033,260
| +770% | +$7.26M | 3.76% | 10 |
|
|
2021
Q3 | $961K | Buy |
+264,100
| New | +$961K | 0.44% | 23 |
|
|
2020
Q4 | – | Sell |
-1,205,501
| Closed | -$3.26M | – | 23 |
|
|
2020
Q3 | $3.26M | Buy |
+1,205,501
| New | +$3.26M | 3.39% | 8 |
|
|
2020
Q2 | – | Sell |
-151,189
| Closed | -$357K | – | 23 |
|
|
2020
Q1 | $357K | Buy |
+151,189
| New | +$357K | 0.38% | 25 |
|